spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Prince Helps Sustainable Pharma Packaging Pioneers Woolcool Celebrate 10th Anniversary


The Prince visited Woolcool’s HQ in Staffordshire to learn more about the company’s pioneering use of natural materials in insulated packaging, before unveiling a plaque marking their tenth anniversary in business. Woolcool uses 100% pure sheep’s wool – which is biodegradable, recyclable and reusable - in place of man-made insulators such as polystyrene.

During his visit on July 19, The Prince - who is Patron of The Campaign for Wool – talked with Woolcool staff and met representatives from The National Trust and British Wool, who provide the types of wool used by the company.

His Royal Highness has championed the use of wool by industry since The Campaign for Wool was launched in 2010.

During a speech at the reception, he said: “I have been enormously impressed by the remarkable degree of innovation and ingenuity which is clearly going on in this country in producing fascinating alternatives to synthetic products, artificial products and man-made things.

“For me, having started The Wool Campaign all those years ago, it is important to remind people of how valuable and sustainable wool is as a fibre and as a natural material and Woolcool has taken it further by demonstrating just how important that material is.”

Woolcool specialises in sustainable, insulated packaging for the transportation of temperature-sensitive goods for the food and pharmaceutical sectors. Last year the firm received a Queen's Award for Enterprise in the Innovation category.

Key customers and partners such as Gousto, Abel & Cole and Fortnum and Mason also attended last week’s Royal visit.

Company founder and CEO Angela Morris said: “The Prince’s visit to Woolcool was a wonderful way to mark our tenth anniversary and an event that everyone here will remember for the rest of their lives.

“His Royal Highness was very interested to hear about how we have pioneered a sustainable use of wool in packaging. He also took time to talk to everyone during his visit.”

Strategic Director Keith Spilsbury commented: “The Prince seemed very impressed with our testing facilities – where we put our packaging through vigorous temperature trials – and knew his facts about the challenges we face and the properties of wool.”

Managing director Josie Morris added: “The excitement towards The Prince’s visit has been building for a while. Our Finance Director, Jessica, oversaw so many of the arrangements to get everything just right, but was unfortunately unable to attend on the day.

“We try to create a sense of community at Woolcool, both among our team and with our partners, customers and suppliers, and we wanted today’s visit to be a reflection of that ethos, because so many people have contributed to our success over ten years.

“I would like to thank everyone who joined us on this special occasion to help celebrate our anniversary. To mark this milestone among our friends, and in the presence of His Royal Highness, was truly memorable.”
 
Print this page
Send to a friend
   
spacer
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>


White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement